Different effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injury

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Ci, Xinxin ^a   Chu, Xiao ^a   Wei, Miaomiao ^a   Yang, Xiaofeng ^a   Cai, Qinren ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DEXAMETHASONE; FARREROL; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CHEMOKINE; CHEMOKINE RECEPTOR; CHROMONE DERIVATIVE; CYTOKINE;

ACUTE LUNG INJURY; AIRWAY; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL HYPERPLASIA; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; GOBLET CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG LAVAGE; MOUSE; NONHUMAN; PHENOTYPE; POST EXPOSURE PROPHYLAXIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT ALLERGY; TH1 CELL; TH2 CELL; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BLOOD; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MUS; RHODODENDRON;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHEMOKINES; CHROMONES; CYTOKINES; FEMALE; IMMUNOGLOBULIN E; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; NF-KAPPA B; OVALBUMIN; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS;

EID: 84860371256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034634     Document Type: Article

References (35)

1. Greenberger PA, (2008) 7. Immunologic lung disease. J Allergy Clin Immunol 121: S393-397; quiz S418.
2. Chen H, Bai C, Wang X, (2010) The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med 4: 773-783.
3. Broide DH, Finkelman F, Bochner BS, Rothenberg ME, (2011) Advances in mechanisms of asthma, allergy, and immunology in 2010. J Allergy Clin Immunol 127: 689-695.
4. Rogerio AP, Andrade EL, Leite DF, Figueiredo CP, Calixto JB, (2009) Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation. Br J Pharmacol 158: 1074-1087.
5. Opitz B, van Laak V, Eitel J, Suttorp N, (2010) Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 181: 1294-1309.
6. Kawai T, Akira S, (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
7. Roth M, Black JL, (2006) Transcription factors in asthma: are transcription factors a new target for asthma therapy? Curr Drug Targets 7: 589-595.
8. Barnes PJ, (2006) Transcription factors in airway diseases. Lab Invest 86: 867-872.
9. Pantano C, Ather JL, Alcorn JF, Poynter ME, Brown AL, et al. (2008) Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness. Am J Respir Crit Care Med 177: 959-969.
10. Duan W, Wong WS, (2006) Targeting mitogen-activated protein kinases for asthma. Curr Drug Targets 7: 691-698.
11. Rommel C, Camps M, Ji H, (2007) PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 7: 191-201.
12. Park SJ, Min KH, Lee YC, (2008) Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma. Respirology 13: 764-771.
13. Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, et al. (2004) Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011.
14. Tian J, Liu J, Hu Z, Chen X, (2005) Interaction of wogonin with bovine serum albumin. Bioorg Med Chem 13: 4124-4129.
15. Cao Y, Lou C, Fang Y, Ye J, (2002) Determination of active ingredients of Rhododendron dauricum L. by capillary electrophoresis with electrochemical detection. J Chromatogr A 943: 153-157.
16. Choi SE, Park KH, Han BH, Jeong MS, Seo SJ, et al. (2011) Inhibition of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Expression by Phenolic Compounds from Roots of Rhododendron mucronulatum. Phytother Res.
17. Qiu J, Xiang H, Hu C, Wang Q, Dong J, et al. (2011) Subinhibitory concentrations of farrerol reduce alpha-toxin expression in Staphylococcus aureus. FEMS Microbiol Lett 315: 129-133.
18. Manson SC, Brown RE, Cerulli A, Vidaurre CF, (2009) The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 103: 975-994.
19. Kleiman A, Tuckermann JP, (2007) Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Mol Cell Endocrinol 275: 98-108.
20. Zhou H, Bian D, Jiao X, Wei Z, Zhang H, et al. (2011) Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability. Inflamm Res 60: 981-990.
21. Choi JR, Lee CM, Jung ID, Lee JS, Jeong YI, et al. (2009) Apigenin protects ovalbumin-induced asthma through the regulation of GATA-3 gene. Int Immunopharmacol 9: 918-924.
22. Iwamoto I, Nakajima H, Endo H, Yoshida S, (1993) Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 177: 573-576.
23. Shields CJ, Winter DC, Redmond HP, (2002) Lung injury in acute pancreatitis: mechanisms, prevention, and therapy. Curr Opin Crit Care 8: 158-163.
24. Abraham E, (2003) Neutrophils and acute lung injury. Crit Care Med 31: S195-199.
25. Li QY, Chen L, Zhu YH, Zhang M, Wang YP, et al. (2011) Involvement of estrogen receptor-beta in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation. Acta Pharmacol Sin 32: 433-440.
26. Wang Y, Cela E, Gagnon S, Sweezey NB, (2010) Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res 11: 166.
27. Tritar-Cherif F, Ben M'Rad S, Merai S, Djenayah F, (2002) [Corticotherapy for asthma in the child]. Tunis Med 80: 1-6.
28. Kos-Kudla B, Pluskiewicz W, (1997) Quantitative ultrasound of the heel and serum and urinary cortisol values in assessment of long-term corticotherapy side effects in female bronchial asthma patients. Ultrasound Med Biol 23: 1325-1330.
29. Zhang X, Song K, Xiong H, Li H, Chu X, et al. (2009) Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 9: 1525-1529.
30. Rogerio AP, Fontanari C, Borducchi E, Keller AC, Russo M, et al. (2008) Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur J Pharmacol 580: 262-270.
31. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY, (2004) A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 172: 2903-2908.
32. Edwan JH, Perry G, Talmadge JE, Agrawal DK, (2004) Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation. J Immunol 172: 5016-5023.
33. Bao Z, Lim S, Liao W, Lin Y, Thiemermann C, et al. (2007) Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am J Respir Crit Care Med 176: 431-438.
34. Ito K, Jazrawi E, Cosio B, Barnes PJ, Adcock IM, (2001) p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J Biol Chem 276: 30208-30215.
35. Zhou L, Goldsmith AM, Bentley JK, Jia Y, Rodriguez ML, et al. (2005) 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 33: 195-202.